Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BillionToOne, Inc. - Class A common stock
(NQ:
BLLN
)
89.92
-0.28 (-0.31%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about BillionToOne, Inc. - Class A common stock
BLLN Investors Have Opportunity to Join BillionToOne, Inc. Fraud Investigation with SBS Law
November 21, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
BLLN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into BillionToOne (BLLN)
November 20, 2026
From
Levi & Korsinsky, LLP
Via
ACCESS Newswire
Lost Money on BillionToOne, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 6.32% Share Price Drop
November 19, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
Did You Lose Money on BillionToOne, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 6.32% Share Price Decline
November 19, 2026
From
The Law Offices of Howard G. Smith
Via
Business Wire
Lost Money in BillionToOne, Inc. (NASDAQ: BLLN)? Gibbs Mura is Investigating Potential Securities Law Violations on Behalf of BLLN Investors
November 18, 2026
From
Gibbs Mura
Via
Business Wire
Lost Money on BillionToOne, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 6.32% Stock Decline
November 18, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
BillionToOne Responds to Inaccurate and Misleading Short Seller Report
November 18, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
Rosen Law Firm Encourages BillionToOne, Inc. Investors to Inquire About Securities Class Action Investigation - BLLN
November 18, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
BillionToOne to Participate in the Piper Sandler 38th Annual Healthcare Conference
November 18, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
November 04, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Participate in Two Upcoming Investor Conferences
October 27, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
October 14, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
October 07, 2026
Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
August 05, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
July 15, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
May 27, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
May 06, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
March 04, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 17, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Provides Guidance for 2026
January 12, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Third Quarter 2025 Results
December 09, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
December 02, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 07, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.